|
1
|
Rawla P, Sunkara T and Gaduputi V:
Epidemiology of pancreatic cancer: Global trends, etiology and risk
factors. World J Oncol. 10:10–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mizrahi JD, Surana R, Valle JW and Shroff
RT: Pancreatic cancer. Lancet. 395:2008–2020. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ushio J, Kanno A, Ikeda E, Ando K, Nagai
H, Miwata T, Kawasaki Y, Tada Y, Yokoyama K, Numao N, et al:
Pancreatic ductal adenocarcinoma: Epidemiology and risk factors.
Diagnostics (Basel). 11:5622021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rai V and Agrawal S: Targets (metabolic
mediators) of therapeutic importance in pancreatic ductal
adenocarcinoma. Int J Mol Sci. 21:85022020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feig C, Gopinathan A, Neesse A, Chan DS,
Cook N and Tuveson DA: The pancreas cancer microenvironment. Clin
Cancer Res. 18:4266–4276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Conroy T, Desseigne F, Ychou M, Bouché O,
Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de
la Fouchardière C, et al: FOLFIRINOX versus gemcitabine for
metastatic pancreatic cancer. N Engl J Med. 364:1817–1825. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suker M, Beumer BR, Sadot E, Marthey L,
Faris JE, Mellon EA, El-Rayes BF, Wang-Gillam A, Lacy J, Hosein PJ,
et al: FOLFIRINOX for locally advanced pancreatic cancer: A
systematic review and patient-level meta-analysis. Lancet Oncol.
17:801–810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeng S, Pöttler M, Lan B, Grützmann R,
Pilarsky C and Yang H: Chemoresistance in pancreatic cancer. Int J
Mol Sci. 20:45042019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Florey O and Overholtzer M:
Macropinocytosis and autophagy crosstalk in nutrient scavenging.
Philos Trans R Soc Lond B Biol Sci. 374:201801542019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bryant KL, Mancias JD, Kimmelman AC and
Der CJ: KRAS: Feeding pancreatic cancer proliferation. Trends
Biochem Sci. 39:91–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Piffoux M, Eriau E and Cassier PA:
Autophagy as a therapeutic target in pancreatic cancer. Br J
Cancer. 124:333–344. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Su H, Yang F, Fu R, Li X, French R, Mose
E, Pu X, Trinh B, Kumar A, Liu J, et al: Cancer cells escape
autophagy inhibition via NRF2-induced macropinocytosis. Cancer
Cell. 39:678–693.e11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morishita H and Mizushima N: Diverse
cellular roles of autophagy. Annu Rev Cell Dev Biol. 35:453–475.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sousa CM, Biancur DE, Wang X, Halbrook CJ,
Sherman MH, Zhang L, Kremer D, Hwang RF, Witkiewicz AK, Ying H, et
al: Pancreatic stellate cells support tumour metabolism through
autophagic alanine secretion. Nature. 536:479–483. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Recouvreux MV and Commisso C:
Macropinocytosis: A metabolic adaptation to nutrient stress in
cancer. Front Endocrinol (Lausanne). 8:2612017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Perera RM and Zoncu R: The lysosome as a
regulatory Hub. Annu Rev Cell Dev Biol. 32:223–253. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gupta S, Yano J, Mercier V, Htwe HH, Shin
HR, Rademaker G, Cakir Z, Ituarte T, Wen KW, Kim GE, et al:
Lysosomal retargeting of myoferlin mitigates membrane stress to
enable pancreatic cancer growth. Nat Cell Biol. 23:232–242. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ota K, Okuma T, Lorenzo A, Yokota A, Hino
H, Kazama H, Moriya S, Takano N, Hiramoto M and Miyazawa K:
Fingolimod sensitizes EGFR wild-type non-small cell lung cancer
cells to lapatinib or sorafenib and induces cell cycle arrest.
Oncol Rep. 42:231–242. 2019.PubMed/NCBI
|
|
19
|
Zhang N, Qi Y, Wadham C, Wang L, Warren A,
Di W and Xia P: FTY720 induces necrotic cell death and autophagy in
ovarian cancer cells: A protective role of autophagy. Autophagy.
6:1157–1167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao A, Hu R, Zhao Q, Li J, Li Y, Yao K,
Zhang R, Wang H, Yang W and Liu Z: Autophagy induced by FTY720
promotes apoptosis in U266 cells. Eur J Pharm Sci. 45:600–605.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Wang H, Ding K and Xu J: FTY720
induces autophagy-related apoptosis and necroptosis in human
glioblastoma cells. Toxicol Lett. 236:43–59. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Wang SW, Zhang DS, Sun Y, Zhu CY,
Fei Q, Hu J, Zhang C and Sun YM: FTY720-induced enhancement of
autophagy protects cells from FTY720 cytotoxicity in colorectal
cancer. Oncol Rep. 35:2833–2842. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alinari L, Mahoney E, Patton J, Zhang X,
Huynh L, Earl CT, Mani R, Mao Y, Yu B, Quinion C, et al: FTY720
increases CD74 expression and sensitizes mantle cell lymphoma cells
to milatuzumab-mediated cell death. Blood. 118:6893–6903. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Trkov S, Stenovec M, Kreft M, Potokar M,
Parpura V, Davletov B and Zorec R: Fingolimod-a sphingosine-like
molecule inhibits vesicle mobility and secretion in astrocytes.
Glia. 60:1406–1416. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahmed D, de Verdier PJ, Ryk C, Lunqe O,
Stål P and Flygare J: FTY720 (Fingolimod) sensitizes hepatocellular
carcinoma cells to sorafenib-mediated cytotoxicity. Pharmacol Res
Perspect. 3:e001712015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tay KH, Liu X, Chi M, Jin L, Jiang CC, Guo
ST, Verrills NM, Tseng HY and Zhang XD: Involvement of vacuolar
H(+)-ATPase in killing of human melanoma cells by the sphingosine
kinase analogue FTY720. Pigment Cell Melanoma Res. 28:171–183.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X, Wang MH, Qin C, Fan WH, Tian DS and
Liu JL: Fingolimod suppresses neuronal autophagy through the
mTOR/p70S6K pathway and alleviates ischemic brain damage in mice.
PLoS One. 12:e01887482017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Min KJ and Kwon TK: Induction of lysosomal
membrane permeabilization is a major event of FTY720-mediated
non-apoptotic cell death in human glioma cells. Cancers (Basel).
12:33882020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aizawa S, Yaguchi M, Nakano M, Toyama K,
Inokuchi S, Imai T, Yasuda M, Nabeshima R and Handa H:
Hematopoietic supportive function of human bone marrow stromal cell
lines established by a recombinant SV40-adenovirus vector. Exp
Hematol. 22:482–487. 1994.PubMed/NCBI
|
|
30
|
Kazama H, Hiramoto M, Miyahara K, Takano N
and Miyazawa K: Designing an effective drug combination for ER
stress loading in cancer therapy using a real-time monitoring
system. Biochem Biophys Res Commun. 501:286–292. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Iwawaki T, Akai R, Kohno K and Miura M: A
transgenic mouse model for monitoring endoplasmic reticulum stress.
Nat Med. 10:98–102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kaizuka T, Morishita H, Hama Y, Tsukamoto
S, Matsui T, Toyota Y, Kodama A, Ishihara T, Mizushima T and
Mizushima N: An autophagic flux probe that releases an internal
control. Mol Cell. 64:835–849. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saito Y, Moriya S, Kazama H, Hirasawa K,
Miyahara K, Kokuba H, Hino H, Kikuchi H, Takano N, Hiramoto M, et
al: Amino acid starvation culture condition sensitizes
EGFR-expressing cancer cell lines to gefitinib-mediated
cytotoxicity by inducing atypical necroptosis. Int J Oncol.
52:1165–1177. 2018.PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Aizawa S, Hiramoto M, Hoshi H, Toyama K,
Shima D and Handa H: Establishment of stromal cell line from an MDS
RA patient which induced an apoptotic change in hematopoietic and
leukemic cells in vitro. Exp Hematol. 28:148–155. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nadanaciva S, Lu S, Gebhard DF, Jessen BA,
Pennie WD and Will Y: A high content screening assay for
identifying lysosomotropic compounds. Toxicol In Vitro. 25:715–723.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chou TC: Theoretical basis, experimental
design, and computerized simulation of synergism and antagonism in
drug combination studies. Pharmacol Rev. 58:621–681. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chiba K, Kataoka H, Seki N, Shimano K,
Koyama M, Fukunari A, Sugahara K and Sugita T: Fingolimod (FTY720),
sphingosine 1-phosphate receptor modulator, shows superior efficacy
as compared with interferon-β in mouse experimental autoimmune
encephalomyelitis. Int Immunopharmacol. 11:366–372. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
White C, Alshaker H, Cooper C, Winkler M
and Pchejetski D: The emerging role of FTY720 (fingolimod) in
cancer treatment. Oncotarget. 7:23106–23127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Heymach JV, Nilsson M, Blumenschein G,
Papadimitrakopoulou V and Herbst R: Epidermal growth factor
receptor inhibitors in development for the treatment of non-small
cell lung cancer. Clin Cancer Res. 12:4441s–4445s. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Legrand C, Bour JM, Jacob C, Capiaumont J,
Martial A, Marc A, Wudtke M, Kretzmer G, Demangel C, Duval D, et
al: Lactate dehydrogenase (LDH) activity of the cultured eukaryotic
cells as marker of the number of dead cells in the medium
[corrected]. J Biotechnol. 25:231–243. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Crowley LC, Marfell BJ, Scott AP and
Waterhouse NJ: Quantitation of apoptosis and necrosis by annexin V
binding, propidium iodide uptake, and flow cytometry. Cold Spring
Harb Protoc 2016. 2016. View Article : Google Scholar
|
|
43
|
Duriez PJ and Shah GM: Cleavage of
poly(ADP-ribose) polymerase: A sensitive parameter to study cell
death. Biochem Cell Biol. 75:337–349. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rogakou EP, Boon C, Redon C and Bonner WM:
Megabase chromatin domains involved in DNA double-strand breaks in
vivo. J Cell Biol. 146:905–916. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rogakou EP, Nieves-Neira W, Boon C,
Pommier Y and Bonner WM: Initiation of DNA fragmentation during
apoptosis induces phosphorylation of H2AX histone at serine 139. J
Biol Chem. 275:9390–9395. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Patel T, Gores GJ and Kaufmann SH: The
role of proteases during apoptosis. FASEB J. 10:587–597. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Degterev A, Hitomi J, Germscheid M, Ch'en
IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, et al:
Identification of RIP1 kinase as a specific cellular target of
necrostatins. Nat Chem Biol. 4:313–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Aruoma OI, Halliwell B, Hoey BM and Butler
J: The antioxidant action of N-acetylcysteine: Its reaction with
hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous
acid. Free Radic Biol Med. 6:593–597. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wu YT, Tan HL, Huang Q, Kim YS, Pan N, Ong
WY, Liu ZG, Ong CN and Shen HM: Autophagy plays a protective role
during zVAD-induced necrotic cell death. Autophagy. 4:457–466.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang F, Gómez-Sintes R and Boya P:
Lysosomal membrane permeabilization and cell death. Traffic.
19:918–931. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Serrano-Puebla A and Boya P: Lysosomal
membrane permeabilization as a cell death mechanism in cancer
cells. Biochem Soc Trans. 46:207–215. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cremer T, Neefjes J and Berlin I: The
journey of Ca2+ through the cell-pulsing through the
network of ER membrane contact sites. J Cell Sci.
133:jcs2491362020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lemasters JJ, Nieminen AL, Qian T, Trost
LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA,
Brenner DA and Herman B: The mitochondrial permeability transition
in cell death: A common mechanism in necrosis, apoptosis and
autophagy. Biochim Biophys Acta. 1366:177–196. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kim I, Rodriguez-Enriquez S and Lemasters
JJ: Selective degradation of mitochondria by mitophagy. Arch
Biochem Biophys. 462:245–253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ponnambalam S, Girotti M, Yaspo ML, Owen
CE, Perry AC, Suganuma T, Nilsson T, Fried M, Banting G and Warren
G: Primate homologues of rat TGN38: Primary structure, expression
and functional implications. J Cell Sci. 109:675–685. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ghosh RN, Mallet WG, Soe TT, McGraw TE and
Maxfield FR: An endocytosed TGN38 chimeric protein is delivered to
the TGN after trafficking through the endocytic recycling
compartment in CHO cells. J Cell Biol. 142:923–936. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Di Martino R, Sticco L and Luini A:
Regulation of cargo export and sorting at the trans-Golgi network.
FEBS Lett. 593:2306–2318. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hino H, Iriyama N, Kokuba H, Kazama H,
Moriya S, Takano N, Hiramoto M, Aizawa S and Miyazawa K:
Abemaciclib induces atypical cell death in cancer cells
characterized by formation of cytoplasmic vacuoles derived from
lysosomes. Cancer Sci. 111:2132–2145. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ohkuma S and Poole B: Fluorescence probe
measurement of the intralysosomal pH in living cells and the
perturbation of pH by various agents. Proc Natl Acad Sci USA.
75:3327–3331. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Mackenzie AH: Pharmacologic actions of
4-aminoquinoline compounds. Am J Med. 75:5–10. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Appelqvist H, Nilsson C, Garner B, Brown
AJ, Kagedal K and Ollinger K: Attenuation of the lysosomal death
pathway by lysosomal cholesterol accumulation. Am J Pathol.
178:629–639. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Appelqvist H, Sandin L, Björnström K,
Saftig P, Garner B, Ollinger K and Kågedal K: Sensitivity to
lysosome-dependent cell death is directly regulated by lysosomal
cholesterol content. PLoS One. 7:e502622012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kornhuber J, Henkel AW, Groemer TW,
Städtler S, Welzel O, Tripal P, Rotter A, Bleich S and Trapp S:
Lipophilic cationic drugs increase the permeability of lysosomal
membranes in a cell culture system. J Cell Physiol. 224:152–164.
2010.PubMed/NCBI
|
|
64
|
Villamil Giraldo AM, Appelqvist H, Ederth
T and Öllinger K: Lysosomotropic agents: Impact on lysosomal
membrane permeabilization and cell death. Biochem Soc Trans.
42:1460–1464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lu S, Sung T, Lin N, Abraham RT and Jessen
BA: Lysosomal adaptation: How cells respond to lysosomotropic
compounds. PLoS One. 12:e01737712017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Anand A, Liu B, Dicroce Giacobini J, Maeda
K, Rohde M and Jäättelä M: Cell death induced by cationic
amphiphilic drugs depends on lysosomal Ca2+ release and
cyclic AMP. Mol Cancer Ther. 18:1602–1614. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Llanos S, Megias D, Blanco-Aparicio C,
Hernández-Encinas E, Rovira M, Pietrocola F and Serrano M:
Lysosomal trapping of palbociclib and its functional implications.
Oncogene. 38:3886–3902. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Aits S and Jäättelä M: Lysosomal cell
death at a glance. J Cell Sci. 126:1905–1912. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Xu H and Ren D: Lysosomal physiology. Annu
Rev Physiol. 77:57–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Ballabio A and Bonifacino JS: Lysosomes as
dynamic regulators of cell and organismal homeostasis. Nat Rev Mol
Cell Biol. 21:101–118. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Wu Y, Huang P and Dong XP: Lysosomal
calcium channels in autophagy and cancer. Cancers (Basel).
13:12992021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sahara S and Yamashima T: Calpain-mediated
Hsp70.1 cleavage in hippocampal CA1 neuronal death. Biochem Biophys
Res Commun. 393:806–811. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Villalpando Rodriguez GE and Torriglia A:
Calpain 1 induce lysosomal permeabilization by cleavage of
lysosomal associated membrane protein 2. Biochim Biophys Acta.
1833:2244–2253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Phillips MJ and Voeltz GK: Structure and
function of ER membrane contact sites with other organelles. Nat
Rev Mol Cell Biol. 17:69–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Prinz WA, Toulmay A and Balla T: The
functional universe of membrane contact sites. Nat Rev Mol Cell
Biol. 21:7–24. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Vessey DA, Kelley M, Zhang J, Li L, Tao R
and Karliner JS: Dimethylsphingosine and FTY720 inhibit the SK1
form but activate the SK2 form of sphingosine kinase from rat
heart. J Biochem Mol Toxicol. 21:273–279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bandhuvula P, Tam YY, Oskouian B and Saba
JD: The immune modulator FTY720 inhibits sphingosine-1-phosphate
lyase activity. J Biol Chem. 280:33697–33700. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Berdyshev EV, Gorshkova I, Skobeleva A,
Bittman R, Lu X, Dudek SM, Mirzapoiazova T, Garcia JG and Natarajan
V: FTY720 inhibits ceramide synthases and up-regulates
dihydrosphingosine 1-phosphate formation in human lung endothelial
cells. J Biol Chem. 284:5467–5477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Lahiri S, Park H, Laviad EL, Lu X, Bittman
R and Futerman AH: Ceramide synthesis is modulated by the
sphingosine analog FTY720 via a mixture of uncompetitive and
noncompetitive inhibition in an Acyl-CoA chain length-dependent
manner. J Biol Chem. 284:16090–16098. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Dawson G and Qin J: Gilenya (FTY720)
inhibits acid sphingomyelinase by a mechanism similar to tricyclic
antidepressants. Biochem Biophys Res Commun. 404:321–323. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ogretmen B: Sphingolipid metabolism in
cancer signalling and therapy. Nat Rev Cancer. 18:33–50. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Hannun YA and Obeid LM: Principles of
bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol
Cell Biol. 9:139–150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Hannun YA and Obeid LM: Sphingolipids and
their metabolism in physiology and disease. Nat Rev Mol Cell Biol.
19:175–191. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Hayashi A, Hong J and Iacobuzio-Donahue
CA: The pancreatic cancer genome revisited. Nat Rev Gastroenterol
Hepatol. 18:469–481. 2021. View Article : Google Scholar : PubMed/NCBI
|
